These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 26682622)

  • 1. Challenges in modelling nanoparticles for drug delivery.
    Barnard AS
    J Phys Condens Matter; 2016 Jan; 28(2):023002. PubMed ID: 26682622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology in therapeutics: a focus on nanoparticles as a drug delivery system.
    Bamrungsap S; Zhao Z; Chen T; Wang L; Li C; Fu T; Tan W
    Nanomedicine (Lond); 2012 Aug; 7(8):1253-71. PubMed ID: 22931450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the impact of structural diversity on the performance of nanodiamond drug carriers.
    Barnard AS
    Nanoscale; 2018 May; 10(19):8893-8910. PubMed ID: 29737997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chitosan nanoparticle based delivery systems for sustainable agriculture.
    Kashyap PL; Xiang X; Heiden P
    Int J Biol Macromol; 2015; 77():36-51. PubMed ID: 25748851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modeling the interaction of interferon α-1b to bovine serum albumin as a drug delivery system.
    Luo Q; Wang Y; Yang H; Liu C; Ding Y; Xu H; Wang Q; Liu Y; Xie Y
    J Phys Chem B; 2014 Jul; 118(29):8566-74. PubMed ID: 24988473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective overview of the essential requirements in molecular modeling for nanomedicine design.
    Kumar P; Khan RA; Choonara YE; Pillay V
    Future Med Chem; 2013 May; 5(8):929-46. PubMed ID: 23682569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanoparticles in targeted cancer therapy: mesoporous silica nanoparticles entering preclinical development stage.
    Rosenholm JM; Mamaeva V; Sahlgren C; Lindén M
    Nanomedicine (Lond); 2012 Jan; 7(1):111-20. PubMed ID: 22191780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adaptive micro and nanoparticles: temporal control over carrier properties to facilitate drug delivery.
    Yoo JW; Doshi N; Mitragotri S
    Adv Drug Deliv Rev; 2011 Nov; 63(14-15):1247-56. PubMed ID: 21605607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reinvention of chemotherapy: drug conjugates and nanoparticles.
    Nguyen-Ngoc T; Raymond E
    Curr Opin Oncol; 2015 May; 27(3):232-42. PubMed ID: 25783982
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silk fibroin nanoparticle as a novel drug delivery system.
    Mottaghitalab F; Farokhi M; Shokrgozar MA; Atyabi F; Hosseinkhani H
    J Control Release; 2015 May; 206():161-76. PubMed ID: 25797561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for the intracellular delivery of nanoparticles.
    Chou LY; Ming K; Chan WC
    Chem Soc Rev; 2011 Jan; 40(1):233-45. PubMed ID: 20886124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent advances in the field of nanometric drug carriers.
    Ogier J; Arnauld T; Doris E
    Future Med Chem; 2009 Jul; 1(4):693-711. PubMed ID: 21426033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of new chitosan/carrageenan nanoparticles for drug delivery applications.
    Grenha A; Gomes ME; Rodrigues M; Santo VE; Mano JF; Neves NM; Reis RL
    J Biomed Mater Res A; 2010 Mar; 92(4):1265-72. PubMed ID: 19322874
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-functional nanocarriers for targeted delivery of drugs and genes.
    Jabr-Milane L; van Vlerken L; Devalapally H; Shenoy D; Komareddy S; Bhavsar M; Amiji M
    J Control Release; 2008 Sep; 130(2):121-8. PubMed ID: 18538887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A vision for cyclodextrin nanoparticles in drug delivery systems and pharmaceutical applications.
    Lakkakula JR; Maçedo Krause RW
    Nanomedicine (Lond); 2014 May; 9(6):877-94. PubMed ID: 24981652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Yolk/shell nanoparticles: new platforms for nanoreactors, drug delivery and lithium-ion batteries.
    Liu J; Qiao SZ; Chen JS; Lou XW; Xing X; Lu GQ
    Chem Commun (Camb); 2011 Dec; 47(47):12578-91. PubMed ID: 21863171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorescent organic nanoparticles self-assembled from hexa[p-(carbonyl glycin methyl ester) phenoxy] cyclotriphosphazene in solution.
    Li X; Li Z; Jing Y; Bing B; Li B
    J Colloid Interface Sci; 2012 Jun; 375(1):41-9. PubMed ID: 22421000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanoparticle-cored dendrimers: functional hybrid nanocomposites as a new platform for drug delivery systems.
    Brunetti V; Bouchet LM; Strumia MC
    Nanoscale; 2015 Mar; 7(9):3808-16. PubMed ID: 25566989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in chitosan-based drug delivery vehicles.
    Hu L; Sun Y; Wu Y
    Nanoscale; 2013 Apr; 5(8):3103-11. PubMed ID: 23515527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of nanoparticles for therapeutics.
    Hall JB; Dobrovolskaia MA; Patri AK; McNeil SE
    Nanomedicine (Lond); 2007 Dec; 2(6):789-803. PubMed ID: 18095846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.